百奥赛图股价涨5.02%，中银证券旗下1只基金重仓，持有9万股浮盈赚取32.4万元

Group 1 - The core viewpoint of the news is that BaiO Technology has seen a significant increase in its stock price, rising by 5.02% to 75.25 CNY per share, with a total market capitalization of 33.629 billion CNY [1] - BaiO Technology, established on November 13, 2009, specializes in antibody drug research and preclinical research services, operating five divisions including gene editing services, preclinical pharmacology and efficacy evaluation, model animal sales, antibody development, and innovative drug development focused on oncology and autoimmune diseases [1] - The company is located in the Daxing District of Beijing, within the Zhongguancun Science Park, and is set to be listed on December 10, 2025 [1] Group 2 - According to data, a fund under Bank of China Securities holds a significant position in BaiO Technology, with the Bank of China Health Industry Mixed Fund (002938) owning 90,000 shares, representing 3.82% of the fund's net value, making it the seventh-largest holding [2] - The Bank of China Health Industry Mixed Fund was established on September 7, 2016, with a current scale of 124 million CNY, and has experienced a year-to-date loss of 0.49% [2] - The fund has achieved a one-year return of 24.49% and a cumulative return of 114.52% since its inception, ranking 4485 out of 8127 in its category [2]